Last spring the USNS Comfort was stationed in New York City for approximately one month to help the city cope with the coronavirus pandemic. A Mercy-class hospital ship of the U.S. Navy, the Comfort initially treated non-coronavirus patients and later began accepting patients who had contracted the COVID-19 disease.
Among those assisting with the operations for the USNS Comfort was Michele Tisdale, a Research Associate with the Infectious Disease Clinical Research Program and an HJF employee. Tisdale helped obtain more than 400 specimens from the ship in a secure lab.
“I was able to assist in collection as well as train and assist in processing and storage of the lab specimens,” Tisdale said.
Tisdale also supports a clinical trial known as Protocol 124 that is focused on Remdesivir, an antiviral medication being used as a treatment for COVID-19. Tisdale collects laboratory specimens and helps manage the storage of plasma, serum and swabs in a controlled environment.
“The hope is that this clinical trial will lead to more patients receiving an effective treatment that shortens the length of their hospital stay,” she said.
Back to the Annual Report